Cargando…
miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer
Breast cancer (BC) is a major health burden that affects over one million women each year. It is the most prevalent cancer in women and the number one cancer killer of them worldwide. Of all BC subtypes, estrogen receptor-positive (ER+) BC is the most commonly diagnosed. The objective of this study...
Autores principales: | Msheik, Zahraa S., Nassar, Farah J., Chamandi, Ghada, Itani, Abdul Rahman, Gadaleta, Emanuala, Chalala, Claude, Alwan, Nisreen, Nasr, Rihab R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946945/ https://www.ncbi.nlm.nih.gov/pubmed/35328298 http://dx.doi.org/10.3390/diagnostics12030745 |
Ejemplares similares
-
Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis
por: Ashekyan, Ohanes, et al.
Publicado: (2022) -
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021) -
Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection
por: Nassar, Farah J., et al.
Publicado: (2020) -
A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer
por: Itani, Maha M., et al.
Publicado: (2021) -
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!
por: Chamandi, Ghada, et al.
Publicado: (2023)